CDMO News
Cytovance and ExcellGene: A Strategic Collaboration for Biologics Development
ExcellGene SA, a Swiss biotech service provider specializing in mammalian cell line development, has entered a strategic collaboration with Cytovance Biologics, a contract manufacturing organization (CDMO) based in the U.S. The partnership aims to advance large molecule biologics development and
9 May 2024